NUVL

Nuvalent, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Miller Deborah AnnChief Legal Officer
$182k1.7k shares
SellMay 28, 2026
$109.30
--
Miller Deborah AnnChief Legal Officer
$164k1.5k shares
SellMay 28, 2026
$107.45
--
Noci DarleneChief Development Officer
$164k1.5k shares
SellMay 28, 2026
$109.30
--
Miller Deborah AnnChief Legal Officer
$149k1.4k shares
SellMay 28, 2026
$106.32
--
Noci DarleneChief Development Officer
$153k1.4k shares
SellMay 28, 2026
$107.33
--
Noci DarleneChief Development Officer
$138k1.3k shares
SellMay 28, 2026
$106.26
--

News

globenewswire.comNUVL Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Nuvalent to GSKglobenewswire.comJun 16prnewswire.comAre AVNS, NUVL, XOMA, TBRG Obtaining Fair Deals for their Shareholders?prnewswire.comJun 12marketbeat.comPatent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billionmarketbeat.comJun 11reuters.comProject Nashville: GSK boosts oncology rebuild with $11 billion Nuvalent dealreuters.comJun 11businesswire.comNuvalent Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nuvalent, Inc. - NUVLbusinesswire.comJun 10